| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8730729 | Pancreatology | 2018 | 19 Pages |
Abstract
The association of tumor budding with vimentin expression supported the idea that EMT is a key process in PDAC responsible for progression and drug resistance. Consequently, the elucidation of EMT molecular biology and development of new targeted therapy may improve disease outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ezzeddine Chouat, Alia Zehani, Ines Chelly, Manel Njima, Houcine Maghrebi, Mohammed Amine Bani, Leila Njim, Abdelfatteh Zakhama, Slim Haouet, Nidhameddine Kchir,